Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Gene delivery from a DNA controlled-release stent in porcine coronary arteries

Abstract

Expandable intra-arterial stents are widely used for treating coronary disease. We hypothesized that local gene delivery could be achieved with the controlled release of DNA from a polymer coating on an expandable stent. Our paper reports the first successful transfection in vivo using a DNA controlled-release stent. Green fluorescent protein (GFP) plasmid DNA within emulsion-coated stents was efficiently expressed in cell cultures (7.9% ± 0.7% vs. 0.6% ± 0.2% control, p < 0.001) of rat aortic smooth muscle cells. In a series of pig stent-angioplasty studies, GFP expression was observed in all coronary arteries (normal, nondiseased) in the DNA-treated group, but not in control arteries. GFP plasmid DNA in the arterial wall was confirmed by PCR, and GFP presence in the pig coronaries was confirmed by immunohistochemistry. Thus, DNA-eluting stents are capable of arterial transfection, and could be useful as delivery systems for candidate vectors for gene therapy of cardiovascular diseases.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: DNA within stent coating.
Figure 2: DNA sustained release.
Figure 3: Cell transfection with GFP plasmid DNA into A10 cells using a DNA–PLGA coated stent wire.
Figure 4: Photomicrographs of arteries deployed in vivo with DNA–PLGA coated stents (A and D) or control PLGA-coated stents (B and E).
Figure 5: Representative PCR analyses of tissues for GFP distribution after left circumflex and left anterior descending coronary arterial deployment of DNA–PLGA coated stents in vivo.

Similar content being viewed by others

References

  1. Serruys, P.W. et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group . N. Engl. J. Med. 331, 489– 495 (1994).

    Article  CAS  Google Scholar 

  2. Fischman, D.L. et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators . N. Engl. J. Med. 331, 496– 501 (1994).

    Article  CAS  Google Scholar 

  3. Moreno, P.R. et al. Histopathologic comparison of human coronary in-stent and post-balloon angioplasty restenotic tissue. Am. J. Cardiol. 84, 462–466, A9 (1999).

    Article  CAS  Google Scholar 

  4. Rome, J.J. et al. Adenoviral vector-mediated gene transfer into sheep arteries using a double-balloon catheter. Hum. Gene Ther. 5, 1249– 58 (1994).

    Article  CAS  Google Scholar 

  5. Stephan, D.J. et al. A new cationic liposome DNA complex enhances the efficiency of arterial gene transfer in vivo. Hum. Gene Ther. 7, 1803–1812 (1996).

    Article  CAS  Google Scholar 

  6. Chang, M.W. et al. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science 267, 518–522 (1995).

    Article  CAS  Google Scholar 

  7. Simari, R.D. et al. Regulation of cellular proliferation and intimal formation following balloon injury in atherosclerotic rabbit arteries. J. Clin. Invest. 98, 225–235 ( 1996).

    Article  CAS  Google Scholar 

  8. Simons, M., Edelman, E.R., DeKeyser, J.L., Langer, R. & Rosenberg, R.D. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature 359, 67– 70 (1992).

    Article  CAS  Google Scholar 

  9. Morishita, R., Gibbons, G.H., Kaneda, Y., Ogihara, T. & Dzau, V.J. Pharmacokinetics of antisense oligodeoxyribonucleotides (cyclin B1 and CDC 2 kinase) in the vessel wall in vivo: enhanced therapeutic utility for restenosis by HVJ-liposome delivery. Gene 149, 13–19 (1994).

    Article  CAS  Google Scholar 

  10. Chang, M.W., Barr, E., Lu, M.M., Barton, K. & Leiden, J.M. Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J. Clin. Invest. 96, 2260–2268 (1995).

    Article  CAS  Google Scholar 

  11. Villa, A.E. et al. Effects of antisense c-myb oligonucleotides on vascular smooth muscle cell proliferation and response to vessel wall injury. Circ. Res. 76, 505–513 ( 1995).

    Article  CAS  Google Scholar 

  12. Cable, D.G. et al. Expression and function of a recombinant endothelial nitric oxide synthase gene in porcine coronary arteries. Cardiovasc. Res. 35, 553–559 (1997).

    Article  CAS  Google Scholar 

  13. Sata, M. et al. Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response. Proc. Natl. Acad. Sci. USA 95, 1213–1217 (1998).

    Article  CAS  Google Scholar 

  14. Luo, Z. et al. Adenovirus-mediated delivery of Fas ligand inhibits intimal hyperplasia after balloon injury in immunologically primed animals. Circulation 99, 1776–1779 (1999).

    Article  CAS  Google Scholar 

  15. Sirois, M.G., Simons, M. & Edelman, E.R. Antisense oligonucleotide inhibition of PDGFR-beta receptor subunit expression directs suppression of intimal thickening. Circulation 95, 669–676 (1997).

    Article  CAS  Google Scholar 

  16. Labhasetwar, V., Bonadio, J., Goldstein, S., Chen, W. & Levy, R.J. A DNA controlled-release coating for gene transfer: transfection in skeletal and cardiac muscle. J Pharm. Sci. 87, 1347–1350 (1998).

    Article  CAS  Google Scholar 

  17. Labhasetwar, V., Bonadio, J., Goldstein, S., Chen, W. & Levy, R.J. Gene transfection using biodegradable nanospheres: results in tissue culture and a rat osteotomy model. Colloids and Surfaces B: Biointerfaces 16, 281–290 (1999).

    Article  CAS  Google Scholar 

  18. Bonadio, J., Smiley, E., Patil, P. & Goldstein, S. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat. Med. 5, 753– 759 (1999).

    Article  CAS  Google Scholar 

  19. Shea, L.D., Smiley, E., Bonadio, J. & Mooney, D.J. DNA delivery from polymer matrices for tissue engineering. Nat. Biotechnol. 17, 551–554 ( 1999).

    Article  CAS  Google Scholar 

  20. Roy, K., Mao, H.Q., Huang, S.K. & Leong, K.W. Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat. Med. 5, 387–391 (1999).

    Article  CAS  Google Scholar 

  21. van der Giessen et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 94, 1690–1697 (1996).

    Article  CAS  Google Scholar 

  22. Lincoff, A.M., Furst, J.G., Ellis, S.G., Tuch, R.J. & Topol, E.J. Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model. J. Am. Coll. Cardiol. 29, 808–816 (1997).

    Article  CAS  Google Scholar 

  23. Yang, R., Lis, J. & Wu, R. Elution of DNA from agarose gels after electrophoresis. Methods Enzymol. 68, 176–182 ( 1979).

    Article  CAS  Google Scholar 

  24. Petersen, M., Hamed, A.A., Pedersen, E.B. & Jacobsen, J.P. Bis-intercalation of homodimeric thiazole orange dye derivatives in DNA. Bioconj. Chem. 10, 66–74 (1999).

    Article  CAS  Google Scholar 

  25. Felgner, P.L. et al. Improved cationic lipid formulations for in vivo gene therapy. Ann. NY Acad. Sci. 772, 126–139 (1995).

    Article  CAS  Google Scholar 

  26. Sells, M.A. & Chernoff, J. Polymerase chain reaction cloning of related genes. Methods Enzymol. 254, 184–195 (1995).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors thank Ms. Ginger Nicholson for her efforts in preparing the manuscript. We also thank Dr. Senator Hazelwood and Dr. Kenneth Ryan, Children's Hospital of Philadelphia, for their critical comments. We also thank Mark Bove and Angela Vicencio for technical assistance. We especially thank Dr. George Papandreou of the Cordis Corporation (Johnson & Johnson), for both making stents available, and providing supportive advice and encouragement. This work was supported in part by a research grant from Selective Genetics, Inc. Robert J. Levy is a recipient of an endowed chair from The Children's Hospital of Philadelphia. Crown stents were supplied by Cordis Corporation, Warren, NJ.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robert J. Levy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Klugherz, B., Jones, P., Cui, X. et al. Gene delivery from a DNA controlled-release stent in porcine coronary arteries. Nat Biotechnol 18, 1181–1184 (2000). https://doi.org/10.1038/81176

Download citation

  • Received:

  • Accepted:

  • Issue date:

  • DOI: https://doi.org/10.1038/81176

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing